THE LATEST FROM US

News archive

Hormone therapy related to reduced coronary heart disease

23.3.2015 – A retrospective nationwide register study finds a positive relation between hormone therapy and reduced coronary heart disease, stroke and all-cause mortality. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Published in Menopaus...

Results of retrospective nationwide register study

16.1.2015 – A retrospective nationwide register study finds no connection between Parkinson’s disease drug entacapone and risk of prostate cancer. Entacapone and Prostate Cancer Risk in Patients With Parkinson’s Disease. Published in Movement Disorders 2015. –  Abstract &...

Women’s Health Initiative study

10.12.2014 – A retrospective nationwide register study on the effects of the “Womens Health Initiative” study on hormone therapy and CHD mortality in Finland: Coronary heart disease mortality and hormone therapy before and after the women’s health initiative. Published in O...

Four posters presented in 17th ISPOR

13.11.2014 – EPID Research presented four posters in  ISPOR 17th Annual European Congress, 8-12 Nov, 2014: – “Patients with COPD who initiate roflumilast in Sweden” – Poster – “Uses of electronic patient information systems and national registers &#8211...

Poster presented in ERS 2014

11.9.2014 – Poster titled “Exacerbations and healthcare resource utilization among COPD patients in Sweden” presented in ERS International Congress 2014, 6-10 Sep, 2014 –  Poster...

Poster presented in 74th ADA

20.7.2014 – Poster titled “Lower risk of mortality in patients with type 2 diabetes using insulin detemir or glargine compared to NPH: a propensity score-matched nationwide register study in Finland” presented in ADA 74th Scientific Session, 13-17 June, 2014, Poster...
Are you interested in learning more about how our RWE solutions can help you in your drug development and surveillance? Our team of experts is eager to discuss your specific needs. To learn more, please contact us at office@epidresearch.com.